PURPOSE: To determine the incidence of hepatic hemangiomas associated with wedge-shaped parenchymal enhancements adjacent to the tumors as seen on two-phase spiral CT images obtained during the hepatic arterial phase and to characterize the two-phase spiral CT findings of those hemangiomas. MATERIALS AND METHODS: One hundred and eight consecutive hepatic hemangiomas in 63 patients who underwent two-phase spiral CT scanning during an 11-month period were included in this study. Two-phase spiral CT scans were obtained during the hepatic arterial phase(30-second delay) and portal venous phase(65-second delay) after injection of 120mL of contrast material at a rate of 3mL/sec. We evaluated the frequency with which wedge-shaped parenchymal enhancement was adjacent to the hemangiomas during the hepatic arterial phase and divided hemangiomas into two groups according to whether or not wedge-shaped parenchymal enhancement was noted (Group A and Group B). The presence of such enhancement in hemangiomas was cor-related with tumor size and the grade of intratumoral enhancement. RESULTS: In 24 of 108 hemangiomas, wedge-shaped parenchymal enhancement adjacent to hepatic tumors was seen on two-phase CT images obtained during the hepatic arterial phase. Mean hemangioma size was 22mm in Group A and 24mm in Group B. There was no statistically significant relationship between lesion size and the presence of wedge-shaped parenchymal enhancement adjacent to a hemangioma. In 91.7% and 1 00% of tumors in Group A, and in 9.6% and 17.8% in Group B, hemangiomas showed more than 50% intra-tumoral enhancement during the arterial and portal venous phase, respectively. Wedge-shaped parenchymal enhancements peripheral to hepatic hemangiomas was more frequently found in tumors showing more than 50% intratumoral enhancement during these two phases(p<0.01). CONCLUSION: Wedge-shaped parenchymal enhancements is not uncommonly seen adjacent to hepatic heman-giomas on two-phase spiral CT images obtained during the hepatic arterial phase. A hemangioma showing-wedge-shaped parenchymal enhancement tends to show more than 50% intratumoral enhancements during the arterial and portal venous phase.